Paperpal Prime Logo

Expert Opinion on Biological Therapy : Impact Factor & More

eISSN: 1744-7682pISSN: 1471-2598

Aims and Scope of Expert Opinion on Biological Therapy

Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974. The journal is also indexed in MEDLINE. Less

Key Metrics

CiteScore
7.2
Eigenfactor
0.005 - 0.01
H-Index
96
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.01
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Biological Therapy

Expert Opinion on Biological Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Biological Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Biological Therapy

Originator versus biosimilar adalimumab in hidradenitis suppurativa: a real-world cohort study
  • 8 Aug 2026
  • Expert Opinion on Biological Therapy
Combining biological matrices with growth factor concentrates: toward standardized protocols in regenerative medicine.
  • 8 Aug 2026
  • Expert opinion on biological therapy
Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study
  • 5 Aug 2026
  • Expert Opinion on Biological Therapy
Gene therapy approaches for inborn errors of immunity: from bench to bedside
  • 3 Aug 2026
  • Expert Opinion on Biological Therapy
Breaking immune exclusion in cold tumors via TGF-β pathway inhibition
  • 31 Jul 2026
  • Expert Opinion on Biological Therapy
Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation
  • 29 Jul 2026
  • Expert Opinion on Biological Therapy
Originator versus biosimilar adalimumab in hidradenitis suppurativa: a real-world cohort study
  • 8 Aug 2026
  • Expert Opinion on Biological Therapy
Combining biological matrices with growth factor concentrates: toward standardized protocols in regenerative medicine.
  • 8 Aug 2026
  • Expert opinion on biological therapy
Twelve-month changes in lipid-derived cardiovascular risk indices among patients with psoriasis receiving biologic therapy: a multicenter real-world retrospective cohort study
  • 5 Aug 2026
  • Expert Opinion on Biological Therapy
Gene therapy approaches for inborn errors of immunity: from bench to bedside
  • 3 Aug 2026
  • Expert Opinion on Biological Therapy
Breaking immune exclusion in cold tumors via TGF-β pathway inhibition
  • 31 Jul 2026
  • Expert Opinion on Biological Therapy
Temporal mismatch in allogeneic iPSC therapies: biological risks and implications for clinical translation
  • 29 Jul 2026
  • Expert Opinion on Biological Therapy

FAQs on Expert Opinion on Biological Therapy